Human immunodeficiency virus and hepatitis C virus: which is the cart, and which is the horse?
Open Access
- 1 September 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (5) , 739
Abstract
SIR—The interesting findings by Martinez-Sierra et al. [1] are subject to alternative interpretations that challenge some of the authors' underlying suppositions. The authors' observation of more-prevalent cirrhosis among patients with CD4+ cell counts ⩽200 cells/mm3 than among patients with CD4+ cells counts >200 cells/mm3 at the time of diagnosis of HIV infection was interpreted as evidence that HIV-induced immunosuppression accelerated hepatitis C virus (HCV) disease. Alternatively, the severity of HCV-induced liver disease could have been the cause, rather than the result, of the accelerated decrease in CD4+ cell counts. The possibility that HCV infection contributed to CD4+ cell count decreases in parallel with the severity of liver disease should not be excluded, given that the analysis by Martinez-Sierra et al. [1] did not take into account factors known to be associated with lower CD4+ cell counts, such as the duration of HIV infection and virus load. The observation in the Swiss HIV Cohort Study [2] that increases in CD4+ cell counts were smaller among HCV-infected patients in whom HIV loads were sustained at undetectable levels by HAART than among HCV-uninfected patients with the same response to treatment is compatible with the premise that liver disease adversely affects CD4+ cell count.Keywords
This publication has 2 references indexed in Scilit:
- Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency VirusClinical Infectious Diseases, 2003
- Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyThe Lancet, 2000